We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-0.38%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.39B
AUM Growth
-$121M
Cap. Flow
-$58.4M
Cap. Flow %
-4.19%
Top 10 Hldgs %
6.53%
Holding
988
New
212
Increased
215
Reduced
286
Closed
237

Top Buys

Rank Stock Value
1
LYV icon
Live Nation Entertainment
LYV
+$5.79M
2
SNPS icon
Synopsys
SNPS
+$5.71M
3
NCNO icon
nCino
NCNO
+$5.46M
4
MTD icon
Mettler-Toledo International
MTD
+$5.42M
5
COUR icon
Coursera
COUR
+$5.26M

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$11M
2
TTD icon
Trade Desk
TTD
+$5.88M
3
ASAN icon
Asana
ASAN
+$5.8M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$5.66M
5
BA icon
Boeing
BA
+$5.43M

Sector Composition

Rank Sector Weight
1 Healthcare 23.57%
2 Technology 22.7%
3 Consumer Discretionary 13.38%
4 Industrials 12.4%
5 Financials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCCI
951
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
-6,960
Closed -$207K
ZYNE
952
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-151,956
Closed -$804K
NEX
953
DELISTED
NexTier Oilfield Solutions Inc.
NEX
-60,381
Closed -$287K
ROCC
954
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
-18,800
Closed -$444K
JNCE
955
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-15,009
Closed -$102K
ATCO
956
DELISTED
Atlas Corp.
ATCO
-17,061
Closed -$243K
LCI
957
DELISTED
Lannett Company, Inc.
LCI
-6,575
Closed -$123K
HYRE
958
DELISTED
HyreCar Inc. Common Stock
HYRE
-55,200
Closed -$1.16M
PRTY
959
DELISTED
Party City Holdco Inc.
PRTY
-77,885
Closed -$727K
CLVS
960
DELISTED
Clovis Oncology, Inc.
CLVS
-11,261
Closed -$65K
HTGM
961
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
-1,292
Closed -$90K
AERI
962
DELISTED
Aerie Pharmaceuticals
AERI
-93,136
Closed -$1.49M
CVET
963
DELISTED
Covetrus, Inc. Common Stock
CVET
-12,525
Closed -$338K
ENDP
964
DELISTED
Endo International plc
ENDP
-110,335
Closed -$516K
SMED
965
DELISTED
Sharps Compliance Corp
SMED
-10,059
Closed -$104K
RDUS
966
DELISTED
Radius Health, Inc.
RDUS
-59,000
Closed -$1.08M
EPZM
967
DELISTED
Epizyme, Inc
EPZM
-141,752
Closed -$1.18M
NPTN
968
DELISTED
NEOPHOTONICS CORP
NPTN
-21,469
Closed -$219K
WBT
969
DELISTED
Welbilt, Inc.
WBT
-163,100
Closed -$3.78M
ATRS
970
DELISTED
Antares Pharma, Inc.
ATRS
-17,086
Closed -$74K
GSKY
971
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
-114,237
Closed -$634K
RESN
972
DELISTED
Resonant Inc.
RESN
-59,100
Closed -$190K
SC
973
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
-123,339
Closed -$4.48M
ODT
974
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
-46,900
Closed -$164K
CVA
975
DELISTED
Covanta Holding Corporation
CVA
-116,700
Closed -$2.06M

Similar funds

PDT Partners's Q3 2021 Portfolio in Review

As of Q3 2021, PDT Partners held 988 positions worth $1.39B, down 8% from $1.51B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

PDT Partners withdrew a net $58.4M in Q3 2021, closing 237 positions and reducing 286 holdings. Its most notable exit was Stellantis, an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Live Nation Entertainment worth $6.26M.

  • PDT Partners's largest Q3 2021 buy was Live Nation Entertainment: 68,700 shares worth $6.26M.
  • PDT Partners added most to Mettler-Toledo International in Q3 2021, an estimated $5.42M increase.
  • PDT Partners's biggest Q3 2021 reduction was Asana, cutting an estimated $5.8M.
  • PDT Partners fully exited Stellantis in Q3 2021, selling an estimated $11M.
  • PDT Partners's ten largest holdings make up 6.5% of its $1.39B portfolio in Q3 2021.
  • PDT Partners opened 212 new positions and closed 237 in Q3 2021.
  • PDT Partners's portfolio value fell 8% quarter-over-quarter to $1.39B.

Based on PDT Partners's 13F filing for Q3 2021, filed 15 Nov 2021.